INFLAME: Towards optimal treatment of inflammatory breast cancer patients<br>A study of the Dutch Breast Cancer Research Group (BOOG); BOOG 2014-05

BOOG (the PI of the study is from University Medical Center Groningen)0 sites200 target enrollmentTBD

ConditionsInflammatory Breast Cancer, INFLAME, IBC

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Inflammatory Breast Cancer, INFLAME, IBC
Sponsor: BOOG (the PI of the study is from University Medical Center Groningen)
Enrollment: 200
Status: Recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

2 years ago

Study Type

Observational non invasive

Investigators

Sponsor

BOOG (the PI of the study is from University Medical Center Groningen)

Eligibility Criteria

Inclusion Criteria

•In order to be eligible to participate in this study, a subject must meet all of the following criteria:
•\- Gender: female

Exclusion Criteria

•potential subject being incapacitated or for any reason unable to provide informed consent will be excluded from participation in this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting

Phase 1

Treatment of gum disease to reduce cardiovascular risk

ACTRN12619001573145Western Sydney Local Health District60

Active, not recruiting

Not Applicable

Réponse au stress inflammatoire et traitement par hydroxyurée dans la drépanocytosee protocole de recherche translationnelle prévoit de comparer 3 groupes de patients drépanocytaires et un groupe témoin.Cette étude a pour but de comparer les marqueurs plasmatiques de l'inflammation de 20 enfants drépanocytaires (âgés de plus de 3 ans) traités par HYDREAR, 20 enfants non traités (âgés de plus de 3 ans) avec des crises fréquentes, 20 enfants non traités (âgés de plus de 5 ans) asymptomatiques et 20 sujets non drépanocytaires (enfants ou adultes).MedDRA version: 8.1Level: PTClassification code 10051835Term: Drepanocytosis

EUCTR2008-005077-35-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)

Recruiting

Not Applicable

Predicting the response to therapy of inflammatory bowel disease with infrared spectroscopyK51K50Ulcerative colitisCrohn disease [regional enteritis]

DRKS00033130niversitätsklinikum Erlangen1,500

Completed

Not Applicable

Effect of ibuprofen + caffeine administration on the reduction of dental sensitivity from in-office bleaching

RBR-48c9xtniversidade Estadual de Ponta Grossa - UEPG

Active, not recruiting

Phase 1

Application of intravenous lidocaïne and/or during surgery leads to a reduction of inflammation after breast cancer surgeryBreast cancer patients who undergo surgery for treatment.Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]

EUCTR2012-002222-70-NLniversity Medical Centre St Radboud48